Zolmitriptan 2.5mg orodispersible tablets sugar free

Država: Velika Britanija

Jezik: engleski

Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivni sastojci:

Zolmitriptan

Dostupno od:

Zentiva Pharma UK Ltd

ATC koda:

N02CC03

INN (International ime):

Zolmitriptan

Doziranje:

2.5mg

Farmaceutski oblik:

Orodispersible tablet

Administracija rute:

Oral

Razred:

No Controlled Drug Status

Tip recepta:

Valid as a prescribable product

Proizvod sažetak:

BNF: 04070401; GTIN: 5000283655084

Uputa o lijeku

IB-CSP-approved 17/10/14
PACKAGE LEAFLET: INFORMATION FOR THE USER
ZOLMITRIPTAN 2.5MG ORODISPERSIBLE TABLETS
ZOLMITRIPTAN 5MG ORODISPERSIBLE TABLETS
READ ALL OF THIS LEAFLET CAREFULLY, BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their symptoms are the same as yours.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Zolmitriptan is and what it is used for
2.
What you need to know before you take Zolmitriptan
3.
How to take Zolmitriptan
4.
Possible side effects
5.
How to store Zolmitriptan
6.
Contents of the pack and other information
1. WHAT ZOLMITRIPTAN IS AND WHAT IT IS USED FOR
The name of your medicine is Zolmitriptan 2.5mg orodispersible tablets
or Zolmitriptan 5mg
orodispersible tablets (called Zolmitriptan throughout this leaflet).
Zolmitriptan orodispersible tablets contains the active substance
zolmitriptan and belongs to a
group of medicines called triptans.
Zolmitriptan is used to TREAT MIGRAINE ATTACKS (headaches and nausea).
Migraine symptoms may be caused by swollen blood vessels in the head.
Zolmitriptan
reduces the widening of these blood vessels. This helps to take away
the headache and other
symptoms of a migraine attack, such as feeling or being sick (nausea
or vomiting) and being
sensitive to light and sound.
Zolmitriptan works only when a migraine attack has started. It will
not stop you from getting
an attack.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZOLMITRIPTAN
DO NOT TAKE ZOLMITRIPTAN IF YOU

are allergic (hypersensitive) to zolmitriptan or any of the other
ingredients of this medicine
(listed in section 6).

have high blood pressure.

have ever had heart problems, including a heart atta

Svojstava lijeka

OBJECT 1
ZOLMITRIPTAN 2.5MG ORODISPERSIBLE TABLETS
Summary of Product Characteristics Updated 06-Nov-2014 | Zentiva
1. Name of the medicinal product
ZOLMITRIPTAN 2.5 MG
orodispersible tablets
2. Qualitative and quantitative composition
Zolmitriptan 2.5 mg: Each tablet contains 2.5 mg of zolmitriptan.
Excipient: Each tablet contains also 2.5 mg of aspartame.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Orodispersible tablet
Zolmitriptan 2.5 mg orodispersible tablets: White to off-white, round,
flat faced beveled edge uncoated
tablet with '2.5' debossed on one side and plain on other side.
4. Clinical particulars
4.1 Therapeutic indications
Zolmitriptan is indicated for the acute treatment of migraine headache
with or without aura.
4.2 Posology and method of administration
Posology:
The recommended dose of Zolmitriptan to treat a migraine attack is 2.5
mg. It is advisable that
Zolmitriptan is taken as early as possible after the onset of migraine
headache but it is also effective if
taken at a later stage.
If symptoms should recur within 24 hours following an initial
response, a second dose of zolmitriptan
may be taken. If a second dose is required, it should not be taken
within 2 hours of the initial dose. If a
patient does not respond to the first dose, it is unlikely that a
second dose will be of benefit in the same
attack.
If a patient does not achieve satisfactory relief with 2.5 mg doses,
for subsequent attacks 5 mg doses of
Zolmitriptan could be considered. Caution is advised due to an
increased incidence of undesirable effects.
A controlled clinical study failed to demonstrate superiority of the
5mg dose over the 2.5 mg dose.
Nevertheless a 5 mg dose may be of benefit in some patients.
The total daily intake should not exceed 10 mg. Not more than 2 doses
of Zolmitriptan should be taken in
any 24 hour period.
Zolmitriptan is not indicated for prophylaxis of migraine.
Special populations:
_PATIENTS AGED OVER 65 YEARS_
Safety and efficacy of Zolmitriptan in individuals aged over 65 ye